why choose us

First received: February 2, 2023

Clinical Trial: Velusetrag for the Treatment of Chronic Intestinal Pseudo-Obstruction (CIPO).

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: Chronic Intestinal Pseudo-obstruction

Study Type: Interventional


Official Title: Velusetrag for the Treatment of Chronic Intestinal Pseudo-Obstruction (CIPO). A Multicenter, Double-blind, Placebo-controlled, Cross-over, Multiple (n=1) Trial.

Brief Summary: This is a phase II, multicenter, double-blind, placebo-controlled trial to evaluate the efficacy and safety of velusetrag once a day, compared to placebo, in subjects with CIPO.

Read more